Biotech Values

[ghmm]

VRUS:

That (the financing) caught my eye too. In the old days (Internet) one would think a good business strategy would be to use their high priced currency and go on a buying spree. I have no position but would think given their valuation it may make sense (and reduce some risk) to go on a bit of a buying spree in the HCV arena.